logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Sectors
PPBT
Purple Biotech Ltd.
1.55
1 x 1.51
1 x 1.64
bid
ask
+
0.05
3.33%
1 @ 04:00 PM
1.55 +0.00 (0.00%)
Ytd-76.44%
1y-92.95%
1.41
day range
1.69
1.16
52 week range
24.00
Open1.43Prev Close1.50Low1.41High1.69Mkt Cap214.03K
Vol83.31KAvg Vol329.06KEPS-20.63P/E-0.08Forward P/E-1.69
Beta0.38Short Ratio0.43Inst. Own9.33%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1850-d Avg1.81200-d Avg4.771yr Est33.00

PPBT News

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's af

Purple Biotech (PPBT) Expected to Announce Quarterly Earnings on Wednesday
defenseworld.net
Purple Biotech (PPBT) Expected to Announce Quarterly Earnings on Wednesday

Purple Biotech (NASDAQ: PPBT - Get Free Report) will likely be announcing its results before the mar

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window
globenewswire.com
Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity,

Non-human primate (NHP) toxicology study validates the CAPTN-3 masking strategy, with IM1240 showing

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Earnings Scheduled For May 15, 2026
benzinga.com
Earnings Scheduled For May 15, 2026

Purple Biotech Regains Compliance with Nasdaq
globenewswire.com
Purple Biotech Regains Compliance with Nasdaq

Minimum Bid Price Requirement REHOVOT, Israel, March 17, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd

Purple Biotech Announces CEO Transition
globenewswire.com
Purple Biotech Announces CEO Transition

Gil Efron to Step Down as CEO in August 2026 for Health Considerations; Will Continue to Lead Corpor

Purple Biotech Announces Plan to Implement ADS Ratio Change
globenewswire.com
Purple Biotech Announces Plan to Implement ADS Ratio Change

ADS Will Begin Trading Reflecting the Ratio Change on March 2, 2026 REHOVOT, Israel, Feb. 25, 2026 (

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Short Interest in Purple Biotech Ltd. Sponsored ADR (NASDAQ:PPBT) Expands By 29.9%
defenseworld.net
Short Interest in Purple Biotech Ltd. Sponsored ADR (NASDAQ:PPBT) Expands By 29.9%

Purple Biotech Ltd. Sponsored ADR (NASDAQ: PPBT - Get Free Report) saw a large increase in short int

Purple Biotech (NASDAQ:PPBT) Shares to Reverse Split on Monday, March 2nd
defenseworld.net
Purple Biotech (NASDAQ:PPBT) Shares to Reverse Split on Monday, March 2nd

Purple Biotech Ltd. Sponsored ADR (NASDAQ: PPBT) shares are going to reverse split on the morning of

Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress
globenewswire.com
Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at th

New data showcase the versatility and anti-tumor activity of the CAPTN-3 platform and its unique mul

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update

Initiated development of a second CAPTN-3 tri-specific antibody targeting TROP2 Manufacturing milest
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Dow Surges 250 Points; Verizon Posts Mixed Q3 Results
benzinga.com
Dow Surges 250 Points; Verizon Posts Mixed Q3 Results
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform
globenewswire.com
Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3

Achieved commercially viable yield for IM1240, positioning the program competitively for future deve

Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification
globenewswire.com
Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification

REHOVOT, Israel, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Com

Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants
globenewswire.com
Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to

REHOVOT, Israel, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Co
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
globenewswire.com
Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

REHOVOT, Israel, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Com

Purple Biotech Reports Second Quarter 2025 Financial Results
globenewswire.com
Purple Biotech Reports Second Quarter 2025 Financial Results

Platform validating preclinical data presented at EACR 2025 for CAPTN-3 tri-specific T cell engager

Purple Biotech CEO Issues Letter to Shareholders Highlighting Pipeline Progress and Clinical Milestones Achieved in First Half of 2025
globenewswire.com
Purple Biotech CEO Issues Letter to Shareholders Highlighting Pipeline Progress and Clinical Milesto

REHOVOT, Israel, July 23, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Com

Purple Biotech Highlights Significant Advantages of the Novel CAPTN-3 Tri-Specific Antibody Platform at the EACR 2025 Annual Congress
globenewswire.com
Purple Biotech Highlights Significant Advantages of the Novel CAPTN-3 Tri-Specific Antibody Platform

REHOVOT, Israel, June 23, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Com

Purple Biotech Reports First Quarter 2025 Financial Results
globenewswire.com
Purple Biotech Reports First Quarter 2025 Financial Results

Final CM24 Phase 2 data presented at AACR Annual Meeting 2025, strengthening patient selection strat

Purple Biotech Appoints Shai Lankry as Chief Financial Officer
globenewswire.com
Purple Biotech Appoints Shai Lankry as Chief Financial Officer

U.S.-based Lankry brings over 20 years of financial leadership in biotech and healthcare with a prov

Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head and Neck Cancers
globenewswire.com
Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head and Neck Cancers

REHOVOT, Israel, April 28, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Co

Purple Biotech Reports Fourth Quarter and Full-Year 2024 Financial Results
globenewswire.com
Purple Biotech Reports Fourth Quarter and Full-Year 2024 Financial Results

Completed successful clinical trials for CM24 and NT21 9 oncology assets , demonstrating clinical be
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a pro
benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 1076 companies hit new 52-week lows.
benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 588 stocks hit new 52-week lows.